
Sudafed, Tylenol, DayQuil, NyQuil and Store Brand Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Diesel et al. v. The Procter & Gamble Co.
22-cv-892, E.D. Mo.
(July 2022)
Meza et al. v. The Procter & Gamble Co.
23-cv-241, S.D. Ohio
(Jan. 2023)
DayQuil cough medicine
Falsely marketing medicine as “non-drowsy” when an ingredient (dextromethorphan hydrobromide, or DXM) causes drowsiness
Pending
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
These brand-relationship disclosures are far from world-class.
Instant replay shows six instances in which Super Bowl 52 advertisers have fumbled ad claims.
Ad Watchdog TINA.org Files FTC Complaint MADISON, CONN. January 23, 2018 – Despite a national advertising campaign showcasing patriotic imagery, highlighting its Boston headquarters, and heavily promoting its “Made in…
TINA.org files FTC complaint over Gillette’s false and deceptive Made in the USA claims.
The U.S. flag features prominently in this Gillette ad despite the fact that many of its products aren’t “Made in the USA.”